Literature DB >> 21874591

Clinical features of 405 Japanese patients with systemic sclerosis.

Atsushi Hashimoto1, Hirahito Endo, Hirobumi Kondo, Shunsei Hirohata.   

Abstract

We aimed to clarify the clinical features of Japanese patients with systemic sclerosis (SSc), especially with reference to organ involvement and autoantibodies. A cohort of 405 patients with SSc who attended our institution from 1973 to 2008 was identified retrospectively. Data on clinical features, including autoantibodies, organ involvement, and overlap of other connective tissue diseases, were obtained by following the medical records until 2009. The percentage of male patients during or after 1990 was greater than that before 1990 (3.9 vs. 10.6%, respectively). Limited cutaneous SSc (lSSc) was twice as frequent as diffuse cutaneous SSc (dSSc). About half of the patients had lung involvement (50.4%), while only 3.2% had scleroderma renal crisis. Male gender was associated with lung involvement, and dSSc was associated with most organ involvements except for pulmonary arterial hypertension (PAH). Anti-Scl-70 antibody was associated with lung or heart involvement, while anti-U1-RNP antibody was only associated with PAH. Conversely, patients with anti-centromere antibody had less organ involvement. SSc-Sjögren overlap syndrome was related to lSSc, further overlapping systemic lupus erythematosus (SLE), and less lung or heart involvement. In conclusion, these results not only confirmed previous reports but revealed several other findings, such as the increased proportion of male patients in recent years and the relationships between clinical features.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21874591     DOI: 10.1007/s10165-011-0515-7

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  11 in total

1.  Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease?

Authors:  Ramya Janardana; Aswin M Nair; Ajit K Surin; John Anthony Jude Prakash; Mahasampath Gowri; Debashish Danda
Journal:  Clin Rheumatol       Date:  2019-07-15       Impact factor: 2.980

2.  Quantitative volumetric assessment of pulmonary involvement in patients with systemic sclerosis.

Authors:  Mehmet Güli Çetinçakmak; Cemil Göya; Cihad Hamidi; Güven Tekbaş; Özlem Abakay; İbrahim Batmaz; Salih Hattapoğlu; Alpaslan Yavuz; Aslan Bilici
Journal:  Quant Imaging Med Surg       Date:  2016-02

3.  Comparison of the clinical phenotype of systemic sclerosis patients in Iran and France in two university centers.

Authors:  Yannick Allanore; Farhad Gharibdoost; Ahmad Reza Jamshidi; Ali Javinani; Jérôme Avouac; Elnaz Rastkar; Sadid Hooshmandi; Hoda Kavosi
Journal:  J Scleroderma Relat Disord       Date:  2018-11-20

4.  Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis.

Authors:  Sapol Thepwiwatjit; Suranut Charoensri; Wichien Sirithanaphol; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Chingching Foocharoen
Journal:  J Scleroderma Relat Disord       Date:  2022-07-24

Review 5.  Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.

Authors:  Robyn T Domsic
Journal:  Curr Opin Rheumatol       Date:  2014-11       Impact factor: 5.006

Review 6.  Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

7.  Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.

Authors:  Pia Moinzadeh; Elisabeth Aberer; Keihan Ahmadi-Simab; Norbert Blank; Joerg H W Distler; Gerhard Fierlbeck; Ekkehard Genth; Claudia Guenther; Ruediger Hein; Joerg Henes; Lena Herich; Ilka Herrgott; Ina Koetter; Alexander Kreuter; Thomas Krieg; Kathrin Kuhr; Hanns-Martin Lorenz; Florian Meier; Inga Melchers; Hartwig Mensing; Ulf Mueller-Ladner; Christiane Pfeiffer; Gabriela Riemekasten; Miklós Sárdy; Marc Schmalzing; Cord Sunderkoetter; Laura Susok; Ingo H Tarner; Peter Vaith; Margitta Worm; Gottfried Wozel; Gabriele Zeidler; Nicolas Hunzelmann
Journal:  Ann Rheum Dis       Date:  2014-01-03       Impact factor: 19.103

8.  Clinical Manifestation and Incidence of Cardiopulmonary Complications in Early Systemic Sclerosis Patients with Different Antibody Profiles.

Authors:  Suparaporn Wangkaew; Narawudt Prasertwittayakij; Juntima Euathrongchit
Journal:  J Clin Med Res       Date:  2019-06-11

9.  Therapeutic efficacy of combined glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis for skin sclerosis in diffuse systemic sclerosis.

Authors:  Kensuke Suga; Hiroyuki Yamashita; Yuko Takahashi; Daisuke Katagiri; Fumihiko Hinoshita; Hiroshi Kaneko
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

10.  Characteristics of patients with systemic sclerosis living in Qatar.

Authors:  Fiaz Alam; Hani Malallah Abdulaziz; Irfan Ul Haq; Salah Mohamed Mahdy; Abdul Rahim Mohammed Siam; Prem Chandra; Samar Al Emadi
Journal:  Qatar Med J       Date:  2019-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.